We use cookies to provide you with a better experience. By clicking the Accept button, you are agreeing to our use of cookies in accordance with our Privacy Policy.
  • Patient Resources
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
    • Glossary
  • Professional Resources
    • Research Center Profiles
    • Industry Provider Profiles
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • Patient Education
    • SOPs
  • About Us
  • Contact Us
  • Advertise
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » CenterWatch, Plutus Capital launch Clinical Trials Quarterly

CenterWatch, Plutus Capital launch Clinical Trials Quarterly

October 24, 2011
CenterWatch Staff

CenterWatch and Plutus Capital Partners have launched Clinical Trials Quarterly, a co-branded newsletter for the contract research organization (CRO) industry that expands CenterWatch’s reach to financial clients in Asia and Europe.

The quarterly newsletter, with an initial distribution base of over 700, covers CROs, with a particular focus on the financial and business aspects of the industry.

Each issue will feature an M&A Tracker of all of the quarter’s biggest CRO mergers and acquisitions, a recap of the quarter’s CRO strategic partnerships, top headlines and news on R&D trends. It also will include interviews with industry insiders and a look at top pharmaceutical and biotechnology company drug development pipelines.

“This partnership leverages Plutus’ deal experience and network in the CRO space, with CenterWatch’s industry insights, so as to provide companies with access to information that can guide their strategic objectives,” said Ripun Jai Mehta, managing partner, Plutus Capital Partners.

“This strategic collaborative partnership with Plutus Capital provides us the opportunity to share clinical trials content with the financial community in Asia and Europe, who are tracking all activity within the industry,” said Joan Chambers, chief operating officer of CenterWatch. “In a time of increased M&As and strategic partnerships, it’s important to keep all industry stakeholders well informed—this collaboration provides that opportunity for Plutus Capital and CenterWatch.”

Global News CROs/Service Providers

Upcoming Events

  • 16Dec

    Master the Regulatory Pathway for Cell & Gene Therapy Submissions: Strategies for Successful BLAs

Featured Products

  • Regenerative-medicine-steps-to-accelerate-development-pdf

    Regenerative Medicine: Steps to Accelerate Development — PDF

  • Clinical-trial-agreements-a-guide-to-key-words-and-phrases-pdf

    Clinical Trial Agreements: A Guide to Key Words and Phrases — PDF

Featured Stories

  • Ich_logo

    ICH Overhauls 22-Year-Old Clinical Studies Guideline

  • Survey_chart2019

    Sponsors, CROs Doing Better, Sites Say, But More Work Is Needed

  • China-360x240

    U.S. Tops List of Trial Startups With China Making Progress in Phase 1

  • Phoneapp-360x240

    Device Apps Present Unique Risks in Trials

New!

2019 Site Survey Reports

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2019. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing